Canopy Growth (CGC) Cash from Investing Activities (2019 - 2025)

Canopy Growth (CGC) reported Cash from Investing Activities of $15.3 million for Q4 2025, up 1645.86% on a YoY basis from $874704.2 in Q4 2024, and up 3101.35% sequentially from -$508807.3 in Q2 2025.

Canopy Growth (CGC) Cash from Investing Activities (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Cash from Investing Activities data on file, last reported at $15.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 1645.86% year-over-year to $15.3 million; the trailing twelve-month figure through Dec 2025 stood at $12.1 million (up 157.27% YoY), and the FY2026 full-year result was -$15.6 million, up 53.26% from the prior year.
  • Cash from Investing Activities advanced to $15.3 million in Q4 2025, from -$508807.3 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $260.8 million in Q3 2021 to a low of -$438.7 million in Q1 2021.
  • A 5-year average of $11.3 million and a median of $6.3 million in 2023 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities plunged 788.29% in 2021 and jumped 1645.86% in 2025, its largest moves.
  • Tracing CGC's Cash from Investing Activities over 5 years: stood at -$19.7 million in 2021, then surged by 605.86% to $99.5 million in 2022, then sank by 100.45% to -$448801.2 in 2023, then plunged by 120.11% to -$987871.8 in 2024, then jumped by 1645.86% to $15.3 million in 2025.
  • Business Quant data shows CGC's Cash from Investing Activities at $15.3 million in Q4 2025, -$508807.3 in Q2 2025, and -$987871.8 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.91 Bn 88.04 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.17 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.05 Bn 20.89 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Canopy Growth 276.14 Mn 10.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 15.27 Mn
Dec 31, 2025 15.27 Mn
Jun 30, 2025 -508,807.31
Jun 30, 2025 -508,807.31
Dec 31, 2024 -987,871.81
Dec 31, 2024 -987,871.81
Sep 30, 2024 -1.63 Mn
Sep 30, 2024 -1.63 Mn
Jun 30, 2024 -31.58 Mn
Jun 30, 2024 -31.58 Mn
Mar 31, 2024 12.98 Mn
Mar 31, 2024 12.98 Mn
Dec 31, 2023 -448,801.21
Dec 31, 2023 -448,801.21
Sep 30, 2023 44.86 Mn
Sep 30, 2023 44.86 Mn
Jun 30, 2023 106.14 Mn
Jun 30, 2023 106.14 Mn
Mar 31, 2023 67.50 Mn
Mar 31, 2023 67.50 Mn